South Africa is getting ready for a breakthrough that could change the country’s health story for good: the registration and introduction of a brand-new tuberculosis vaccine, currently in Phase 3 clinical trials.
Briefing the media on Friday, Minister in the Presidency Khumbudzo Ntshavheni said Cabinet had been updated on progress towards the development of the vaccine, which could significantly contribute to eliminating TB as a public health threat in South Africa.
“Cabinet noted that government is preparing for the registration and introduction of the vaccine, should the trials prove successful,” Ntshavheni said, according to SAnews.
Made for the world, boosting jobs at home
The good news does not stop at prevention. Cabinet also welcomed an agreement with the Serum Institute of India – the world’s largest vaccine maker – to produce TB vaccines for global distribution.
The agreement is expected to strengthen South Africa’s vaccine manufacturing capacity, support local innovation, and contribute to economic growth and job creation. In other words, a vaccine that protects South Africans could also employ them.
TB has long been one of South Africa’s most stubborn health challenges, which is exactly why this moment matters. A modern, effective vaccine – the first major advance of its kind in a century of TB prevention – would be a game-changer for families and communities across the country. Government is not waiting for the finish line to prepare: the groundwork for registration and rollout is being laid now, so that if the Phase 3 trials succeed, South Africans can benefit without delay.
Part of a bigger winning streak for SA health and trade
The vaccine update came in a Cabinet briefing packed with encouraging news. Ministers also welcomed the extension of the African Growth and Opportunity Act until 31 December 2028, keeping preferential access to the United States market for South African products, and a landmark agreement with India that expands treatment options for South African citrus exports after nearly a decade of negotiations.
That citrus deal builds on an industry already flying high: South Africa exported 2.9 million tonnes of citrus in 2025, earning 2.1 billion US dollars for the economy.
Cabinet further welcomed the launch of the Electronic Travel Authorisation platform, which replaces manual visa processes with a faster, more efficient digital system – a boost for tourism, business and investment.
Why this matters
Taken together, the message from Friday’s briefing is one of momentum. South Africa is positioning itself not just as a recipient of global health innovation, but as a manufacturer and distributor of it – with the scientific muscle to help protect the world from TB while creating opportunities at home.
For the millions of South Africans whose lives have been touched by tuberculosis, the finish line of a long fight may finally be coming into view.
Photo: commons.wikimedia.org
.jpg){kind=link}
Leave a Reply